Company Overview

ICU develops, manufactures, and sells innovative medical products for infusion therapy, vascular access, and vital care applications. The product portfolio includes ambulatory, syringe, and large volume IV pumps with safety software; dedicated and non-dedicated IV sets; needle-free IV connectors; IV catheters, sharps safety products, and sterile IV solutions; closed-system transfer devices; pharmacy compounding systems, and a variety of respiratory, anesthesia, patient monitoring, and temperature management products. Founded in 1984 and headquartered in San Clemente, California, ICU serves acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities. The acquisition of Pfizer’s Hospira Infusion Systems business in February 2017 expanded ICU’s offerings, including IV solutions, pumps, and non-dedicated infusion sets. Starting January 1, 2023, the business unit consists of Consumables, Infusion Systems, and Vital Care. On December 31, 2024, the company had approximately 15,000 employees in over 35 countries.

Company's Business Segments

• Consumables : The company offers a complete line of infusion, vascular access and speciality chemicals.
• Infusion Systems : The company offers a portfolio of IV pump technologies, informatics and services.
• Vital Care : The company offers hemodynamic monitoring, temperature, and airway management, and pain kits .